fda status bpc 157 2026 ghk-cu approval ๐จ The FDA just changed the rules on peptides โ effective Big FDA review coming this
Description
Excess B12 from high oral doses is primarily excreted through urine, which contributes to its low toxicity profile
Authorization requirements also vary by setting: an injection performed in an ASC may require separate authorization from the same injection performed in a physician office

When reconstituting, draw bacteriostatic water into a sterile syringe

Different concentration
